Ajanta Pharma Q4 Results: Revenue, margins miss estimates as Africa

During the fiscal year, Ajanta Pharma distributed a total of ₹700 crore (₹349 crore as dividend and ₹351 crore in the form of buyback). This translates to 76% payout of the total PAT of the year.

Source